by Market Overview:
Cluster headaches are a rare type of primary headache disorder characterized by severe pain on one side of the head. These headaches are usually associated with autonomic symptoms like watery eye, nasal congestion. Non-invasive treatments like transcutaneous vagus nerve stimulation (tVNS) which involve electronic stimulation of vagus nerve at the ear are gaining popularity as fast growing treatment segment in the market.
Market key trends:
One of the key trends in the cluster headache market is the rising adoption of neuromodulation therapies such as tVNS. These devices help modulate pain signals to the brain through electric stimulation of cranial nerves. They provide a safer alternative to pharmaceutical therapies and aim to offer quick relief from acute attacks. With advantages such as lower side effects and non-invasiveness, tVNS is emerging as an important treatment avenue for cluster headaches.
Segment Analysis
The global cluster headache market is segmented into treatment type, route of administration and distribution channel. Based on treatment type, it is segmented into drugs and medical devices. Drugs segment holds a dominant share in the market due to its high usage and affordability. Triptans is the largest sub-segment under drugs owing to its effectiveness in treating cluster headaches.
Key Takeaways
The Global Cluster Headache Market Demand is expected to reach US$ 646.48 Mn by 2030, expanding at a CAGR of 6.4% over the forecast period. The market is expected to grow at a significant rate owing to the increasing prevalence of cluster headaches around the world.
Regional Analysis
North America dominates the global cluster headache market and is expected to maintain its position over the forecast period. High awareness about the condition and easy availability of treatment options in the region is a key factor responsible for its large share. Europe is the second largest regional market due to high healthcare penetration.
Key Players
Key players operating in the cluster headache market are Zosano Pharma, Eli Lilly and Company, Lundbeck Seattle BioPharmaceutical, Winston Laboratories, GlaxoSmithKline plc., ElectroCore Medical LLC, Autonomic Technologies, Inc., AstraZeneca plc., Allergan plc., Bayer AG, F. Hoffmann-La Roche Ltd, Novartis AG, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Sanofi, and AbbVie Inc. Major players are focusing on new product development and geographic expansion to strengthen their market position.
Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
